• SENSEX 81,451.01
    -182.01 (--0.22%)
  • BANKNIFTY 55,749.70
    203.65 (+0.37%)
  • Suzlon Energy
    74.30 86.04(%)
  • Reliance Power
    60.50 60.50(%)
  • Swiggy
    338.00 617.00(%)
  • Mazagon Dock
    3,450.00 1,200.00(%)
  • Eternal Ltd
    243.00 304.50(%)
  • MMTC
    88.20 131.88(%)
  • Garden Reach Sh.
    2,926.85 1,148.10(%)
  • Waaree Energies
    2,956.60 1,808.65(%)
  • Indian Energy Ex
    203.20 244.35(%)
  • Bharat Dynamics
    2,096.00 2,096.00(%)
  • Engineers India
    239.00 304.00(%)
  • NBCC
    126.41 139.83(%)
  • IFCI
    66.71 35.67(%)
  • Muthoot Finance
    2,241.75 2,444.65(%)
  • HDFC Bank
    1,948.60 1,977.95(%)
  • LMW
    16,640.85 13,456.85(%)
  • Hind.Aeronautics
    4,962.00 3,045.95(%)
  • Pidilite Inds.
    3,127.25 3,414.40(%)
  • Infosys
    1,555.10 1,307.10(%)
  • Ola Electric
    48.07 45.55(%)
  • Overview
  • Key Ratios
  • Financials
  • Shareholding
  • Company Info
  • Peer Comparison
Overview
  • Overview
  • Key Ratios
  • Financials
  • Shareholding
  • Company Info
  • Peer Comparison

Everest Organics Ltd Pharmaceuticals - Indian - Bulk Drugs

  • Indian Private
  • BSE Code : 4614.0
  • ISIN : INE334C01029
426.30 -13 (-2.89%)
  • As on 31 May 2025 (EOD)

  • Today’s Low

    420.00

  • Today’s High

    450.00

  • Open

    450.00

  • Perv Close

    439.00

  • 52W Low

    112.50

  • 52W High

    477.00

Key Indicators

  • P/E(TTM)

    0.00

  • Mar.Cap (₹Cr.)

    413.96

  • Div & Yield %

    0.00

  • Book Value(₹)

    72.04

  • Debt-Equity Ratio

    -2.89

  • AGM Date

    30-May-2025

  • EPS

    0.00

  • P/E Ratio

    0.00

Financials Ratios

  • Debt-Equity Ratio

    -

  • Mar.Cap (₹Cr.)

    413.96

  • RONW (%)

    -

  • ROCE (%)

    -

Score Board

  • Equity (₹ in Cr.)

    9.71

  • BV (₹)

    72.00

  • Sales( ₹ in Cr.)

    159.48

  • NP (in Cr.)

    -1.29

  • NP Var(%)

    -1027.0

  • Div%

    0.0

  • CPS (₹)

    4.80

  • EPS (₹)

    -1.30

  • Traded Value (₹ in Lakhs)

    413.96

  • 52 Week High

    477.00

  • 52 Week Low

    112.50

  • Price BSE

    426.0

  • Price NSE

    0.00

  • Market Capital( in Cr.)

    413.96

  • P/C Ratio

    88.50

  • P/E Ratio

    -320.60

  • Price Vs.BV

    -1.30

View More
Invest Now!

Navigate The Market With Confidence

Your all-in-one destination for expert investment guidance and streamlined portfolio management solutions

Financials

All Values are in (₹Cr)
Particulars(INCOME) 2024 Mar 2023 Mar 2022 Mar 2021 Mar 2020 Mar 2019 Mar
INCOME :            
Sales Turnover 226.49 208.73 230.22 207.36 189.61 177.77
Excise Duty 29.25 25.69 30.17 25.79 22.40 21.92
Net Sales 197.24 183.04 200.05 181.57 167.21 155.85
Other Income 0.89 6.94 2.21 1.06 1.45 0.54
Stock Adjustments -0.56 3.23 4.51 8.22 5.78 2.15
Total Income 197.57 193.21 206.77 190.85 174.44 158.54
EXPENDITURE :            
Raw Materials 124.64 126.31 141.72 117.13 103.52 97.00
Power and Fuel Cost 15.40 18.88 14.70 12.36 11.85 10.81
Employee Cost 18.80 16.30 16.33 15.26 13.30 11.64
Other Manufacturing Expenses 15.37 13.66 15.80 13.91 14.60 12.64
Selling and Administration Expenses 10.52 9.75 8.66 7.65 7.34 6.33
Miscellaneous Expenses 0.96 0.44 0.92 0.64 3.10 1.75
Employee Benefit Expenses 18.80 16.30 16.33 15.26 13.30 11.64
Less: Preoperative Expenditure 0.00 0.00 0.00 0.00 0.00 0.00
Total Expenses 185.69 185.35 198.13 166.94 153.71 140.17
Operating Profit 11.88 7.87 8.64 23.91 20.73 18.37
Interest 5.47 3.31 3.10 3.26 3.43 3.21
Gross Profit 6.41 4.56 5.54 20.65 17.30 15.16
Depreciation 5.80 4.47 3.80 3.37 3.21 2.84
Profit Before Tax 0.61 0.09 1.74 17.28 14.09 12.32
Current Tax 0.10 0.02 0.29 3.02 2.27 2.70
Fringe Benefit tax 0.00 0.00 0.00 0.00 0.00 0.00
Deferred Tax 0.37 0.26 0.31 0.54 0.93 2.12
Reported Net Profit 0.14 -0.18 1.14 13.72 10.90 7.51
Extraordinary Items 0.00 -0.10 0.00 0.00 0.00 0.00
Adjusted Net Profit 0.14 -0.08 1.14 13.72 10.90 7.51
Adjustment below Net Profit 0.00 0.00 -0.12 -0.14 -0.77 -0.22
P & L Balance brought forward 34.49 38.80 38.58 22.47 13.15 6.95
Statutory Appropriations 0.00 0.00 0.00 0.00 0.00 0.00
Appropriations 0.51 0.40 0.80 1.20 0.80 0.00
P & L Balance carried down 34.11 38.21 38.80 34.85 22.47 14.25
Dividend 0.00 0.00 0.00 0.00 0.00 0.00
Preference Dividend 0.00 0.00 0.00 0.00 0.00 0.00
Equity Dividend (%) 0.00 0.00 0.00 15.00 10.00 10.00
Dividend Per Share(Rs) 0.00 0.00 0.00 1.50 1.00 1.00
Earnings Per Share-Unit Curr 0.17 -0.23 1.43 17.14 13.62 9.39
Earnings Per Share(Adj)-Unit Curr 0.17 -0.23 1.43 17.14 13.62 9.39
Book Value 57.30 57.77 58.50 58.22 42.75 32.47
Book Value(Adj)-Unit Curr 57.30 57.77 58.50 58.22 42.75 32.47

Shareholding Pattern

  • Promoter Group

    61.09%

  • Public Share Holding

    38.91%

Category of Shareholder No of Shares % Holdings Demat Shares Shareholders
A]. Promoter & Group
Foreign (Promoter & Group) - Bodies Corporate 0 0.00 0 0
Foreign (Promoter & Group)-Individuals (Non-Resident / Foreign) 169,128 169,128.00 169,128 169,128
Foreign Promoter(Institutional) 0 0.00 0 0
Promoter Others 0 0.00 0 0
Sub Total 169,128 1.74 169,128 2
[2] INDIAN
Bodies Corporate-Indian (Promoter & Group) 3,949,262 40.67 3,949,262 2
Government(Central / State)-Indian (Promoter & Group) 0 0.00 0 0
Directors & their Relatives-Indian (Promoter & Group) 0 0.00 0 0
Financial Institutions / Banks-Indian (Promoter & Group) 0 0.00 0 0
Individuals / Hindu Undivided Family-Indian (Promoter & Group) 1,813,641 18.68 1,813,641 6
Partnership Firms-Indian (Promoter & Group) 0 0.00 0 0
Persons Acting in Concert 0 0.00 0 0
Trusts 0 0.00 0 0
Others 0 0.00 0 0
Sub Total 5,762,903 59.35 5,762,903 8
Total ShareHolding for Promoter & Group
B]. Publice Share Holding
1] Institution
Government(Central / State) 0 0.00 0 0
Clearing Members 0 0.00 0 0
Corporate Bodies 0 0.00 0 0
Foreign Direct Investments 0 0.00 0 0
Financial Institutions / Banks 2,214 0.02 2,214 2
Foreign Bank 0 0.00 0 0
Foreign Bodies Corporate/OCBs/FBC 0 0.00 0 0
Foreign Collaborators 0 0.00 0 0
Foreign Institutional Investors 0 0.00 0 0
Foreign Venture Capital Investors 0 0.00 0 0
Foreign Institution Other 0 0.00 0 0
Insurance Companies 0 0.00 0 0
Mutual Funds / UTI 0 0.00 0 0
Individuals (Non-Resident / Foreign) 0 0.00 0 0
NSDL Intransit 0 0.00 0 0
Others 36 0.00 36 1
Trusts 0 0.00 0 0
Venture Capital Funds 0 0.00 0 0
Sub total 2,250 0.02 2,250 3
2] Non Institution
Bodies Corporate 1,192,146 12.28 1,184,730 56
Clearing Members 200 0.00 200 1
Directors of their Relatives 0 0.00 0 0
Employees 0 0.00 0 0
Escrow Account 0 0.00 0 0
Foreign Corporate Bodies 0 0.00 0 0
Foreign Direct Investments 0 0.00 0 0
NRIs/Foreign Individuals/Foreign Nationals 252,491 2.60 184,055 153
Foreign Non Institution Other 0 0.00 0 0
Hindu Undivided Families 0 0.00 0 0
Indian Public 0 0.00 0 0
Individuals holding nominal share capital in excess of Rs. 1 lakh 1,134,734 11.69 1,134,734 8
Individuals holding nominal share capital up to Rs. 1 lakh 1,183,426 12.19 932,722 8,524
Market Maker 0 0.00 0 0
NSDL Transit 0 0.00 0 0
Shares in transit 0 0.00 0 0
Societies 0 0.00 0 0
Trust & Foundation 0 0.00 0 0
Others 13,248 0.14 13,248 1
Sub Total 3,776,245 38.89 3,449,689 8,743
Total Public Shareholding
C]. Shares held by Custodians and against which Depository Receipts have been issued
ADR 0 0.00 0 0
GDR 0 0.00 0 0
Other Custodians 0 0.00 0 0
Total Shares held by Custodians and against which Depository Receipts have been issued 0 0.00 0 0
Grand Total ( A + B + C ) 9,710,526 100.00 9,383,970 8,756

Company Background

Everest Organics LtdPharmaceuticals - Indian - Bulk Drugs

  • Everest Organics Ltd
  • BSE Code : 4614.0
  • ISIN : INE334C01029

  • Incorporation Year

    1993

  • Registered Office

    Aroor Village
    Sadasivpet Mandal, Medak,
    Telangana-502291

  • Telephone

    91-8455-250113

  • FAX

    91-8455-250114

  • Chairman

  • Managing Director

  • Company Secretary

    Abdur Rahman

  • Auditor

    P S N Ravishanker & Associates

  • Face Value

    10

  • Listing

    BSE

  • Registrar

    Venture Capital & Corp. Inv.
    12-10-167 ,
    ,Bharath Nagar
    Mumbai - Hyderbad - 500018

Everest Organics Ltd Peer Comparison

Profit & Loss
Financial Ratios
Balance Sheet
Select Company Name LTP (₹) Revenue Sales P/E Ratio ROCE %
Everest Organics 426.30 198.13 226.49 -320.53 5.94
Abbott India 30,453.15 6,097.18 5,848.91 45.75 44.71
Astrazeneca Phar 7,965.20 1,330.33 1,295.53 205.34 33.26
P & G Health Ltd 5,775.85 1,166.89 1,151.26 40.53 39.76
Glaxosmi. Pharma 3,295.00 3,530.73 3,407.25 60.74 44.44
Cipla 1,464.85 17,645.00 16,574.34 22.94 20.10
Amrutanjan Healt 711.95 437.58 421.23 40.50 20.84
Fermenta Biotec. 311.95 315.24 307.09 13.58 4.10
Guj. Themis Bio. 307.95 174.19 169.82 68.74 44.82
Bliss GVS Pharma 131.10 638.96 605.46 20.02 11.19
Ambalal Sarabhai 37.87 11.70 3.81 16.18 1.92